ShareHope Medicine Co., Ltd. (8403.TWO)
TWD 28.6
(-0.17%)
TWD 28.6
(-0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 3.87 Billion | 4.13 Billion | 3.85 Billion | 4.09 Billion | 3.12 Billion |
| Cost of Revenue | 3.14 Billion | 3.15 Billion | 3.01 Billion | 2.91 Billion | 2.47 Billion |
| Gross Profit | 726.37 Million | 983.91 Million | 833.95 Million | 1.17 Billion | 652.9 Million |
| Operating Expenses | 604.18 Million | 646.82 Million | 591.02 Million | 664.82 Million | 509.35 Million |
| Selling, General and Administrative Expenses | 700.26 Million | 718 Million | 664.41 Million | 706.89 Million | 554.93 Million |
| Research and Development Expenses | 12.3 Million | 16.39 Million | - | - | - |
| Other Expenses | -105.28 Million | 36.24 Million | 28.26 Million | -17.57 Million | -45.57 Million |
| Cost and Expenses | 3.75 Billion | 3.8 Billion | 3.6 Billion | 3.58 Billion | 2.98 Billion |
| Operating Income | 119.09 Million | 376.07 Million | 272.24 Million | 496.51 Million | 143.54 Million |
| Interest Expense | 53.66 Million | 38.15 Million | 20.13 Million | 14.52 Million | 15.56 Million |
| Income Tax Expense | 53.71 Million | 95.82 Million | 74.2 Million | 118.01 Million | 25.09 Million |
| Earnings before Tax | 108.98 Million | 339.93 Million | 267.62 Million | 479.09 Million | 204.25 Million |
| Net Income | 124.55 Million | 293.94 Million | 232.66 Million | 247.71 Million | 195.05 Million |
| Earnings Per Share Basic | 0.99 | 2.33 | 1.85 | 1.98 | 1.46 |
| Earnings Per Share Diluted | 0.95 | 2.32 | 1.83 | 1.92 | 1.45 |
| Weighted Average Shares Outstanding | 126.04 Million | 126.04 Million | 126.04 Million | 125.06 Million | 133.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 131.66 Million | 126.9 Million | 127.26 Million | 129.63 Million | 134.77 Million |
| Gross Margin | 0.19 | 0.24 | 0.22 | 0.29 | 0.21 |
| EBIT Margin | 0.13 | 0.17 | 0.15 | 0.17 | 0.09 |
| Profit Margin | 0.03 | 0.07 | 0.06 | 0.06 | 0.06 |
| EBITDA | 485.07 Million | 685.24 Million | 592.51 Million | 712.22 Million | 271.5 Million |
| Earnings Before Tax Margin | 0.03 | 0.09 | 0.07 | 0.12 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.09 Billion | 972.54 Million | 1.06 Billion | 3.87 Billion | 969.07 Million | 941.17 Million |
| Cost of Revenue | 894.22 Million | 801.29 Million | 843.24 Million | 3.14 Billion | 821.78 Million | 752.77 Million |
| Gross Profit | 197.51 Million | 171.25 Million | 223.63 Million | 726.37 Million | 147.29 Million | 188.39 Million |
| Operating Expenses | 153.38 Million | 148.42 Million | 168.67 Million | 604.18 Million | 134.04 Million | 157.11 Million |
| Selling, General and Administrative Expenses | 187.81 Million | 166.99 Million | 185 Million | - | 178.75 Million | 171.71 Million |
| Research and Development Expenses | 3.71 Million | 2.08 Million | 2.37 Million | - | 4.03 Million | 3.32 Million |
| Other Expenses | 39.53 Million | 14.25 Million | 2.22 Million | 37.08 Million | 7.94 Million | 8.22 Million |
| Cost and Expenses | 1.04 Billion | 949.71 Million | 1.01 Billion | 3.75 Billion | 955.83 Million | 909.88 Million |
| Operating Income | 86.67 Million | 38.52 Million | 60.85 Million | 165.74 Million | 20.81 Million | 42.61 Million |
| Interest Expense | 13.78 Million | 14.12 Million | 13.37 Million | 53.66 Million | 13.74 Million | 13.86 Million |
| Income Tax Expense | 14.01 Million | 10.88 Million | 14.32 Million | 53.71 Million | 13.15 Million | 14.19 Million |
| Earnings before Tax | 64.69 Million | 24.38 Million | 46.34 Million | 108.98 Million | 7.04 Million | 28.51 Million |
| Net Income | 71.16 Million | 24.52 Million | 44.69 Million | 124.55 Million | 9.67 Million | 32.78 Million |
| Earnings Per Share Basic | 0.56 | 0.19 | 0.35 | - | 0.08 | 0.26 |
| Earnings Per Share Diluted | 0.56 | 0.19 | 0.35 | - | 0.08 | 0.26 |
| Weighted Average Shares Outstanding | 127.07 Million | 129.1 Million | 127.57 Million | 126.04 Million | 120.9 Million | 127.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 127.07 Million | 129.1 Million | 127.85 Million | 126.6 Million | 120.9 Million | 127.5 Million |
| Gross Margin | 0.18 | 0.18 | 0.21 | 0.19 | 0.15 | 0.20 |
| EBIT Margin | 0.15 | 0.12 | 0.13 | - | 0.11 | 0.13 |
| Profit Margin | 0.07 | 0.03 | 0.04 | 0.03 | 0.01 | 0.03 |
| EBITDA | 165.08 Million | 118.08 Million | 140.41 Million | - | 102.74 Million | 124.92 Million |
| Earnings Before Tax Margin | 0.08 | 0.04 | 0.06 | 0.04 | 0.02 | 0.05 |
JAWA
ACT
CHFLF
3093
PRCT
FCPB